Effects of Sialic Acid Modifications on Virus Binding and Infection

Trends in Microbiology

Volumn 24, Issue 12, 2016, Pages 991-1001

  Wasik, Brian R ^a   Barnard, Karen N ^a   Parrish, Colin R ^a  

^a Cornell University ^*  (United States)

Author keywords

inhibitor.; modification; receptor; sialic acids; virus

Indexed keywords

2 KETO 3 DEOXYNONONIC ACID; CD22 ANTIGEN; CYTIDINE PHOSPHATE N ACYLNEURAMINATE PHOSPHODIESTERASE; HEMAGGLUTININ; N ACETYLNEURAMINIC ACID; N GLYCOLOYLNEURAMINIC ACID; SIALIC ACID; SIALIDASE; UNCLASSIFIED DRUG; POLYSACCHARIDE; SIALIC ACID DERIVATIVE; VIRUS RECEPTOR;

AVULAVIRUS; BETACORONAVIRUS; BOCAPARVOVIRUS; CARBOHYDRATE SYNTHESIS; CARBOVIRUS; CELL DIFFERENTIATION; COLORECTAL CANCER; ENDOPLASMIC RETICULUM; ENTEROVIRUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; GOLGI COMPLEX; HEPATITIS VIRUS; HUMAN; IN VITRO STUDY; INFECTIOUS SALMON ANEMIA VIRUS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA C VIRUS; LEUKEMIA; MALARIA; MASS SPECTROMETRY; NONHUMAN; ORBIVIRUS; PICORNAVIRIDAE; POLYOMAVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTOPARVOVIRUS; REOVIRIDAE; RESPIROVIRUS; REVIEW; ROTAVIRUS; RUBULAVIRUS; SIGNAL TRANSDUCTION; TOROVIRUS; VIRAL TROPISM; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS STRAIN; ANIMAL; CHEMISTRY; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; VIRION;

ANIMALS; AVULAVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; N-ACETYLNEURAMINIC ACID; POLYSACCHARIDES; RECEPTORS, VIRUS; SIALIC ACIDS; VIRAL TROPISM; VIRION; VIRUS ATTACHMENT;

EID: 84997207176     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2016.07.005     Document Type: Review

References (99)

1. 1 Corfield, A.P., Mucins: a biologically relevant glycan barrier in mucosal protection. Biochem. Biophys. Acta 1850 (2015), 236–252.
2. 2 Deplancke, B., Gaskins, H.R., Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am. J. Clin. Nutr., 73, 2001 1131S–1141A.
3. 3 Thornton, D.J., et al. Structure and function of the polymeric mucins in airways mucus. Annu. Rev. Physiol. 70 (2008), 459–486.
4. 4 Knowles, M.R., Boucher, R.C., Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin Invest. 109 (2002), 571–577.
5. 5 Stehle, T., Khan, Z.M., Rules and exceptions: sialic acid variants and their role in determining viral tropism. J. Virol. 88 (2014), 7696–7699.
6. 6 Stencel-Baerenwald, J.E., et al. The sweet spot: defining virus-sialic acid interactions. Nature Rev. Microbiol. 12 (2014), 739–749.
7. 7 Varki, A., Essentials of Glycobiology. 2009, Cold Spring Harbor Laboratory Press.
8. 8 Angata, T., Varki, A., Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem. Rev. 102 (2002), 439–469.
9. 9 Muhlenhoff, M., et al. Polysialic acid: three-dimensional structure, biosynthesis and function. Curr. Opin. Struct. Biol. 8 (1998), 558–564.
10. 10 Varki, A., et al. Developmental abnormalities in transgenic mice expressing a sialic acid-specific 9-O-acetylesterase. Cell 65 (1991), 65–74.
11. 11 Bruses, J.L., Rutishauser, U., Roles, regulation, and mechanism of polysialic acid function during neural development. Biochimie 83 (2001), 635–643.
12. 12 Kawai, H., et al. Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J. Biol. Chem. 276 (2001), 6885–6888.
13. 13 Wipfler, D., et al. Differentially regulated expression of 9-O-acetyl GD3 (CD60b) and 7-O-acetyl-GD3 (CD60c) during differentiation and maturation of human T and B lymphocytes. Glycobiology 21 (2011), 1161–1172.
14. 14 Cariappa, A., et al. B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase. J. Exp. Med. 206 (2009), 125–138.
15. 15 Mandal, C., et al. Regulation of O-acetylation of sialic acids by sialate-O-acetyltransferase and sialate-O-acetylesterase activities in childhood acute lymphoblastic leukemia. Glycobiology 22 (2012), 70–83.
16. 16 Shi, W.X., et al. Sialic acid 9-O-acetylation on murine erythroleukemia cells affects complement activation, binding to I-type lectins, and tissue homing. J. Biol. Chem. 271 (1996), 31526–31532.
17. 17 Shen, Y., et al. O-acetylation and de-O-acetylation of sialic acids in human colorectal carcinoma. Eur. J. Biochem. 271 (2004), 281–290.
18. 18 Varki, A., Multiple changes in sialic acid biology during human evolution. Glycoconjugate J. 26 (2009), 231–245.
19. 19 Arming, S., et al. The human Cas1 protein: a sialic acid-specific O-acetyltransferase?. Glycobiology 21 (2011), 553–564.
20. 20 Baumann, A.-M.T.M., et al. 9-O-Acetylation of sialic acids is catalysed by CASD1 via a covalent acetyl-enzyme intermediate. Nature Commun., 6, 2015, 7673.
21. 21 Iwersen, M., et al. Solubilisation and properties of the sialate-4-O-acetyltransferase from guinea pig liver. Biol. Chem. 384 (2003), 1035–1047.
22. 22 Kamerling, J.P., et al. Migration of O-acetyl groups in N,O-acetylneuraminic acids. Eur. J. Biochem. 162 (1987), 601–607.
23. 23 Langereis, M.A., et al. The murine coronavirus hemagglutinin-esterase receptor-binding site: a major shift in ligand specificity through modest changes in architecture. PLoS Pathog., 8, 2012, e1002492.
24. 24 Harduin-Lepers, A., et al. The human sialyltransferase family. Biochimie 83 (2001), 727–737.
25. 25 Li, Y., Chen, X., Sialic acid metabolism and sialyltransferases: natural functions and applications. Appl. Environ. Microbiol. Biotechnol. 94 (2012), 887–905.
26. 26 Aamelfot, M., et al. The in situ distribution of glycoprotein-bound 4-O-Acetylated sialic acids in vertebrates. Glycoconjugate J. 31 (2014), 327–335.
27. 27 Langereis, M.A., et al. Complexity and diversity of the mammalian sialome revealed by Nidovirus Virolectins. Cell Rep. 11 (2015), 1966–1978.
28. 28 Rinninger, A., et al. Localisation and distribution of O-acetylated N-acetylneuraminic acids, the endogenous substrates of the hemagglutinin-esterases of murine coronaviruses, in mouse tissue. Glycoconjugate J. 23 (2006), 73–84.
29. 29 Hashimoto, Y., et al. Further studies on the red cell glycolipids of various breeds of dogs. A possible assumption about the origin of Japanese dogs. J. Biochem. 96 (1984), 1777–1782.
30. 30 Ng, P.S., et al. Ferrets exclusively synthesize Neu5Ac and express naturally humanized influenza A virus receptors. Nature Commun., 5, 2014, 5750.
31. 31 Samraj, A.N., et al. A red meat-derived glycan promotes inflammation and cancer progression. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 542–547.
32. 32 Springer, S.A., et al. Parallel evolution of a self-signal: humans and new world monkeys independently lost the cell surface sugar Neu5Gc. Immunogenetics 66 (2014), 671–674.
33. 33 Varki, N.M., Varki, A., Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab. Invest. 87 (2007), 851–857.
34. 34 Martin, M.J., et al. Evolution of human-chimpanzee differences in malaria susceptibility: relationship to human genetic loss of N-glycolylneuraminic acid. Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 12819–12824.
35. 35 Biddle, F., et al. Properties of horse serum gamma inhibitor. Nature 207 (1965), 381–383.
36. 36 Pepper, D.S., The sialic acids of horse serum with special reference to their virus inhibitory properties. Biochem. Biophys. Acta 156 (1968), 317–326.
37. 37 Rogers, G.N., et al. Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants. Virology 131 (1983), 394–408.
38. 38 Kazi, L., et al. Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence. J. Virol. 79 (2005), 15064–15073.
39. 39 Liu, X., et al. O-acetylation of sialic acids in N-glycans of Atlantic salmon (Salmo salar) serum is altered by handling stress. PROTEOMICS 8 (2008), 2849–2857.
40. 40 Martin, L.T., et al. Recombinant influenza C hemagglutinin-esterase as a probe for sialic acid 9-O-acetylation. Meth. Enzymol. 363 (2003), 489–498.
41. 41 Vlasak, R., et al. Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proc. Natl. Acad. Sci. U.S.A. 85 (1988), 4526–4529.
42. 42 Hause, B.M., et al. Characterization of a novel influenza virus in cattle and swine: proposal for a new genus in the Orthomyxoviridae family. MBio, 5, 2014, 14.
43. 43 Song, H., et al. An open receptor-binding cavity of hemagglutinin-esterase-fusion glycoprotein from newly-identified Influenza D Virus: basis for its broad cell tropism. PLoS Pathog., 12, 2016, e1005411.
44. 44 Munoz-Barroso, I., et al. Increased influenza A virus sialidase activity with N-acetyl-9-O-acetylneuraminic acid-containing substrates resulting from influenza C virus O-acetylesterase action. Virus Res. 25 (1992), 145–153.
45. 45 Byres, E., et al. Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin. Nature 456 (2008), 648–652.
46. 46 Campanero-Rhodes, M.A., et al. N-glycolyl GM1 ganglioside as a receptor for simian virus 40. J. Virol. 81 (2007), 12846–12858.
47. 47 Neu, U., et al. Structural basis of GM1 ganglioside recognition by simian virus 40. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 5219–5224.
48. 48 O'Hara, S.D., et al. Glycan receptors of the Polyomaviridae: structure, function, and pathogenesis. Curr. Opin. Virol. 7 (2014), 73–78.
49. 49 Yu, X., et al. Structural basis of rotavirus strain preference toward N-Acetyl- or N-glycolylneuraminic acid-containing receptors. J. Virol. 86 (2012), 13456–13466.
50. 50 Banda, K., et al. ‘Sialidase sensitivity’ of rotaviruses revisited. Nature Chem. Biol. 5 (2009), 71–72.
51. 51 Blanchard, H., et al. Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8*). J. Mol. Biol. 367 (2007), 1215–1226.
52. 52 Palese, P., et al. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61 (1974), 397–410.
53. 53 Wagner, R., et al. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev. Med. Virol. 12 (2002), 159–166.
54. 54 Mitnaul, L.J., et al. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J. Virol. 74 (2000), 6015–6020.
55. 55 Corfield, A.P., et al. The specificity of viral and bacterial sialidases for alpha(2-3)- and alpha(2-6)-linked sialic acids in glycoproteins. Biochem. Biophys. Acta 744 (1983), 121–126.
56. 56 Corfield, A.P., et al. The action of sialidases on substrates containing O-acetylsialic acids. Biol. Chem. Hoppe-Seyler 367 (1986), 433–439.
57. 57 Xu, G., et al. Sialidase of swine influenza A viruses: variation of the recognition specificities for sialyl linkages and for the molecular species of sialic acid with the year of isolation. Glycoconjugate J. 12 (1995), 156–161.
58. 58 Matrosovich, M., et al. Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host. J. Virol. 72 (1998), 6373–6380.
59. 59 Kryazhimskiy, S., et al. Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet., 7, 2011, e1001301.
60. 60 Neverov, A.D., et al. Coordinated evolution of influenza a surface proteins. PLoS Genet., 11, 2015, e1005404.
61. 61 Poehlmann, S., Simmons, G., Viral Entry Into Host Cells. 2013, Springer-Verlag.
62. 62 Porotto, M., et al. The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion. J. Virol. 86 (2012), 5730–5741.
63. 63 Iorio, R.M., et al. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity. J. Virol. 75 (2001), 1918–1927.
64. 64 Porotto, M., et al. Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site. J. Virol. 80 (2006), 1204–1213.
65. 65 Streltsov, V.A., et al. Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN). Antiviral Res. 123 (2015), 216–223.
66. 66 Gorbalenya, A.E., et al. Nidovirales: evolving the largest RNA virus genome. Virus Res. 117 (2006), 17–37.
67. 67 de Groot, R.J., Structure, function and evolution of the hemagglutinin-esterase proteins of corona- and toroviruses. Glycoconjugate J. 23 (2006), 59–72.
68. 68 Smits, S.L., et al. Nidovirus sialate-O-acetylesterases: evolution and substrate specificity of coronaviral and toroviral receptor-destroying enzymes. J. Biol. Chem. 280 (2005), 6933–6941.
69. 69 Zeng, Q., et al. Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 9065–9069.
70. 70 Popova, R., Zhang, X., The spike but not the hemagglutinin/esterase protein of bovine coronavirus is necessary and sufficient for viral infection. Virology 294 (2002), 222–236.
71. 71 Desforges, M., et al. The acetyl-esterase activity of the hemagglutinin-esterase protein of human coronavirus OC43 strongly enhances the production of infectious virus. J. Virol. 87 (2013), 3097–3107.
72. 72 Helander, A., et al. The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces. J. Virol. 77 (2003), 7964–7977.
73. 73 Haselhorst, T., et al. Sialic acid dependence in rotavirus host cell invasion. Nature Chem. Biol. 5 (2009), 91–93.
74. 74 Zhang, X., et al. Bluetongue virus coat protein VP2 contains sialic acid-binding domains, and VP5 resembles enveloped virus fusion proteins. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 6292–6297.
75. 75 Liu, Y., et al. Sialic acid-dependent cell entry of human enterovirus D68. Nature Commun., 6, 2015, 8865.
76. 76 Nokhbeh, M.R., et al. Enterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines. J. Virol. 79 (2005), 7087–7094.
77. 77 Zocher, G., et al. A sialic acid binding site in a human picornavirus. PLoS Pathog., 10, 2014, e1004401.
78. 78 Lipton, H.L., et al. Differential usage of carbohydrate co-receptors influences cellular tropism of Theiler's murine encephalomyelitis virus infection of the central nervous system. Glycoconjugate J. 23 (2006), 39–49.
79. 79 Xiong, X., et al. Receptor binding properties of the influenza virus hemagglutinin as a determinant of host range. Curr. Top. Microbiol. Immunol. 385 (2014), 63–91.
80. 80 Velkov, T., The specificity of the influenza B virus hemagglutinin receptor binding pocket: what does it bind to?. J. Mol. Recognit. 26 (2013), 439–449.
81. 81 Rogers, G.N., et al. Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. J. Biol. Chem. 261 (1986), 5947–5951.
82. 82 Santos-Lopez, G., et al. Structure-function analysis of two variants of mumps virus hemagglutinin-neuraminidase protein. Braz. J. Infect. Dis. 13 (2009), 24–34.
83. 83 Suzuki, T., et al. Receptor specificities of human respiroviruses. J. Virol. 75 (2001), 4604–4613.
84. 84 Zaitsev, V., et al. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J. Virol. 78 (2004), 3733–3741.
85. 85 Johnson, F.B., et al. Attachment of bovine parvovirus to sialic acids on bovine cell membranes. J. Gen. Virol. 85 (2004), 2199–2207.
86. 86 Nam, H.-J.J., et al. Identification of the sialic acid structures recognized by minute virus of mice and the role of binding affinity in virulence adaptation. J. Biol. Chem. 281 (2006), 25670–25677.
87. 87 Pudlo, N.A., et al. Symbiotic human gut bacteria with variable metabolic priorities for host mucosal glycans. MBio, 6, 2015 e01282-01215.
88. 88 Vimr, E.R., et al. Diversity of microbial sialic acid metabolism. Microbiol. Mol. Biol. Rev. 68 (2004), 132–153.
89. 89 Phansopa, C., et al. Characterization of a sialate-O-acetyl esterase (NanS) from the oral pathogen Tannerella forsythia that enhances sialic acid release by NanH its cognate sialidase. Biochem. J. 472 (2015), 157–167.
90. 90 Severi, E., et al. Sialic acid utilization by bacterial pathogens. Microbiology 153 (2007), 2817–2822.
91. 91 Vimr, E., Lichtensteiger, C., To sialylate, or not to sialylate: that is the question. Trends Microbiol. 10 (2002), 254–257.
92. 92 Gulati, S., et al. Utilizing CMP-sialic acid analogs to unravel Neisseria gonorrhoeae lipooligosaccharide-mediated complement resistance and design novel therapeutics. PLoS Pathog., 11, 2015, e1005290.
93. 93 Song, J., et al. Structure and function of the Salmonella Typhi chimaeric A(2)B(5) typhoid toxin. Nature 499 (2013), 350–354.
94. 94 Bosch, A.A., et al. Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog., 9, 2013, e1003057.
95. 95 McCullers, J.A., The co-pathogenesis of influenza viruses with bacteria in the lung. Nature Rev. Microbiol. 12 (2014), 252–262.
96. 96 Rynda-Apple, A., et al. Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease. Infect. Immun. 83 (2015), 3764–3770.
97. 97 Nita-Lazar, M., et al. Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding. Mol. Immunol. 65 (2015), 1–16.
98. 98 Siegel, S.J., et al. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe 16 (2014), 55–67.
99. 99 Lehmann, F., et al. Sialic acid-specific lectins: occurrence, specificity and function. Cell. Mol. Life Sci. 63 (2006), 1331–1354.